GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

A New York doctor who treated HIV and AIDS patients sued Gilead for violating the False Claims Act with payments to doctors ...

A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now ...

In Zambia, truck drivers and sex workers have high rates of being HIV positive —- and are at high risk of contracting the ...

An ambitious plan to stop the global threat of AIDS has been derailed. But many are hopeful that progress can be salvaged.

The US administration should clear up the confusion over the future of a widely admired AIDS fund and push for Congress to ...

Dolutegravir is recommended by the World Health Organization (WHO) for infants, children and adults and is the preferred HIV ...

Cuts to sexual health clinics could make eliminating new HIV cases in England by 2030 “impossible”, politicians have warned.

A safety analysis of mRNA vaccination in a phase 1, randomized, open-label clinical trial evaluated the safety and ...

The Uganda AIDS Commission (UAC) has reported a continued decline in new HIV infections, though the country still falls short ...

Research led by Professor Adrie Bekker is paving the way for an important HIV medicine to be made available to neonates in a way that is both safe and much more convenient than previous options.